Insmed Incorporated
Organization details
- Legal name
- Insmed Incorporated
- Ownership
- Public
- Status
- Active
- Sector (GICS)
- Health Care
- SIC code
- 2834 — Pharmaceutical Preparations
- Jurisdiction of incorporation
- Virginia
- Headquarters city
- Bridgewater
- Headquarters state / province
- New Jersey
- Headquarters country
- United States
- Fiscal year end
- December
- Ticker symbol
- INSM
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0001104506
- EIN
- 54-1972729
Board of directors
-
Alfred Altomari · DirectorSince 2023
-
Carol Schafer · DirectorSince 2023
-
Clarissa Desjardins · DirectorSince 2023
-
David R. Brennan · DirectorSince 2023
-
David W. J. Mcgirr · DirectorSince 2023
-
Elizabeth M. Anderson · DirectorSince 2023
-
Leo Lee · DirectorSince 2023
-
Melvin Sharoky M.D. · DirectorSince 2023
-
Paul Hudson · DirectorSince 2026
-
Utpal Koppikar · DirectorSince 2026
-
William Lewis · Director · Chair and CEOSince 2023
Chief executives
Director election results
Annual meeting of May 13, 2026. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
82.7%
-
88.5%
Board connections
5 of this board's directors also sit on 8 other boards. 8 are in the same sector.
-
BioMarin Pharmaceutical Inc. Same sectorvia Elizabeth M. Anderson
-
C4 Therapeutics Inc. Same sectorvia Utpal Koppikar
-
Immunome Inc. Same sectorvia Carol Schafer
-
Kura Oncology Inc. Same sectorvia Carol Schafer
-
NewAmsterdam Pharma Company N.V. Same sectorvia William Lewis
-
Revolution Medicines Inc. Same sectorvia Elizabeth M. Anderson
-
Rhythm Pharmaceuticals Inc. Same sectorvia David W. J. Mcgirr
-
X4 Pharmaceuticals Inc. Same sectorvia David W. J. Mcgirr
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $0
- 0 purchases by 0 insiders
- Sold, last 12 months
- $156,214,247
- 157 sales by 10 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Oct 19, 2026 | Paul Hudson Director | Grant or award | +6,139 | — | — |
| Oct 19, 2026 | Utpal Koppikar Director | Grant or award | +6,139 | — | — |
| Sep 9, 2026 | David R. Brennan Director | Open-market sale | −25,000 | $124.00 | $3,100,000 |
| Aug 17, 2026 | Melvin Sharoky M.D. Director | Open-market sale | −5,000 | $127.53 | $637,650 |
| Aug 10, 2026 | Roger Adsett Officer (Chief Operating Officer) | Option exercise | +82,280 | $13.67 | $1,124,768 |
| Aug 10, 2026 | Roger Adsett Officer (Chief Operating Officer) | Option exercise | +76,600 | $17.16 | $1,314,456 |
| Aug 10, 2026 | Roger Adsett Officer (Chief Operating Officer) | Option exercise | +80,970 | $30.46 | $2,466,346 |
| Aug 10, 2026 | Roger Adsett Officer (Chief Operating Officer) | Open-market sale | −239,850 | $133.27 | $31,964,810 |
| Aug 6, 2026 | Flammer Martina M.D. Officer (Chief Medical Officer) | Option exercise | +18,278 | $18.95 | $346,368 |
| Aug 6, 2026 | Flammer Martina M.D. Officer (Chief Medical Officer) | Option exercise | +8,895 | $25.83 | $229,758 |
| Aug 6, 2026 | Flammer Martina M.D. Officer (Chief Medical Officer) | Open-market sale | −8,895 | $127.00 | $1,129,665 |
| Aug 6, 2026 | Flammer Martina M.D. Officer (Chief Medical Officer) | Open-market sale | −18,278 | $129.40 | $2,365,173 |
| Jul 23, 2026 | William Lewis Director, Officer (Chair and CEO) | Option exercise | +6,260 | $30.46 | $190,680 |
| Jul 23, 2026 | William Lewis Director, Officer (Chair and CEO) | Option exercise | +4,440 | $17.16 | $76,190 |
| Jul 23, 2026 | William Lewis Director, Officer (Chair and CEO) | Open-market sale | −4,828 | $105.62 | $509,933 |
Peers
Compare boardsOrganizations in the same sector, closest in location and size first.
Questions about Insmed Incorporated
Who is the CEO of Insmed Incorporated?
William Lewis is Insmed Incorporated's Chair and CEO.
How many directors are on Insmed Incorporated's board?
Insmed Incorporated's board has 11 directors: Alfred Altomari, Carol Schafer, Clarissa Desjardins, David R. Brennan, David W. J. Mcgirr, Elizabeth M. Anderson, Leo Lee, Melvin Sharoky M.D., Paul Hudson, Utpal Koppikar and 1 other.
Are Insmed Incorporated insiders buying or selling shares?
Over the last 12 months, Insmed Incorporated insiders made no open-market purchases and sold $156.2 million of shares in 157 sales on the open market, as reported to the SEC on Forms 4 and 5.
Embed this board on your site
Paste this where the board should appear. It always shows the current directors and links back here.
<div data-bod-board="insmed-incorporated"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.